Hypertrophic Cardiomyopathy

Clinical Trial Finder

Many patients with hypertrophic cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients; Comparison of : Global Longitudinal Strain vs. Left Ventricule Ejection Fruction

Condition:   Cardiomyopathy
Intervention:   Device: echocardiography
Sponsor:   Rabin Medical Center
Not yet recruiting - verified September 2016

Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure

Conditions:   Cardiomyopathy, Hypertrophic;   Cardiomyopathy, Hypertrophic, Familial
Intervention:   Drug: Perhexiline
Sponsor:   Heart Metabolics Limited
Recruiting - verified September 2016

Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy

Condition:   Fabry Disease
Intervention:  
Sponsor:   Ulla Feldt-Rasmussen
Enrolling by invitation - verified September 2016

Individualized Early Risk Assessment for Heart Diseases

Conditions:   Cardiomyopathy, Hypertrophic;   Cardiomyopathy, Dilated
Intervention:   Other: Skin biopsy, genotyping and disease phenotyping
Sponsor:   Universitätsklinikum Hamburg-Eppendorf
Recruiting - verified September 2016

Assessment of Wall Thickness in Hypertrophic Cardiomyopathy

Condition:   Hypertrophic Cardiomyopathy
Interventions:   Procedure: Noncontrast echocardiography;   Procedure: Contrast Echocardiography;   Procedure: Cardiac magnetic resonance imaging
Sponsors:   Mayo Clinic;   GE Healthcare
Recruiting - verified September 2016

Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis

Conditions:   Hypertrophic Cardiomyopathy;   Acute Coronary Syndrome
Intervention:   Radiation: 99mTc-NC100692
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting - verified September 2016